India to Myanmar: Erlotinib Export Trade Route
India has recorded 9 verified shipments of Erlotinib exported to Myanmar, representing a combined trade value of $119.0K USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $13.2K USD. The leading Indian exporter is UNITED BIOTECH PRIVATE LIMITED, which accounts for 75% of total export value with 3 shipments worth $89.4K USD. On the buying side, WIN PHARMACY CO LTD is the largest importer in Myanmar with $89.4K USD in purchases. The top 3 suppliers — UNITED BIOTECH PRIVATE LIMITED, BRUCK PHARMA PRIVATE LIMITED, THERDOSE PHARMA PRIVATE LIMITED — together control 94% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Myanmar Erlotinib corridor is one of India's established pharmaceutical export routes, with 9 shipments documented worth a combined $119.0K USD. The route is dominated by UNITED BIOTECH PRIVATE LIMITED, which alone accounts for roughly 75% of all export value, reflecting the consolidated nature of India's erlotinib manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $13.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during January–March, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 17.3%, placing it at rank #8 among India's top erlotinib export destinations globally.
On the import side, key buyers of Indian erlotinib in Myanmar include WIN PHARMACY CO LTD, DIRECTORATE OF PROCUREMENTNAYPYTAW, DIRECTORATE OF PROCUREMENT and 3 others. WIN PHARMACY CO LTD is the single largest importer with 3 shipments valued at $89.4K USD.
Route Characteristics
- Average transit21 days
- Peak seasonQ1
- Primary modeMulti-modal
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#8
- Annual growth+17.3%
- Demand growth+16.8%
- Regulatory ease70/100
Top 10 Indian Erlotinib Exporters to Myanmar
Showing top 10 of 6 Indian suppliers exporting Erlotinib to Myanmar, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | UNITED BIOTECH PRIVATE LIMITED Avg $29.8K per shipment | 3 | $89.4K | 75.1% |
| 2 | BRUCK PHARMA PRIVATE LIMITED Avg $14.3K per shipment | 1 | $14.3K | 12.0% |
| 3 | THERDOSE PHARMA PRIVATE LIMITED Avg $8.4K per shipment | 1 | $8.4K | 7.0% |
| 4 | KHANDELWAL LABORATORIES PRIVATE LIMITED Avg $2.9K per shipment | 2 | $5.9K | 4.9% |
| 5 | MBA PHARMACEUTICALS PRIVATE LIMITED Avg $642 per shipment | 1 | $642 | 0.5% |
| 6 | THERDOSE PHARMA PRIVATE LIMITED Avg $477 per shipment | 1 | $477 | 0.4% |
This table shows the top 10 of 6 Indian companies exporting erlotinib to Myanmar, ranked by total trade value. The listed exporters are: UNITED BIOTECH PRIVATE LIMITED, BRUCK PHARMA PRIVATE LIMITED, THERDOSE PHARMA PRIVATE LIMITED , KHANDELWAL LABORATORIES PRIVATE LIMITED, MBA PHARMACEUTICALS PRIVATE LIMITED, THERDOSE PHARMA PRIVATE LIMITED. UNITED BIOTECH PRIVATE LIMITED is the dominant supplier with 3 shipments worth $89.4K USD, giving it a 75% market share. The top 3 suppliers together account for 94% of the total trade value on this route.
Top 10 Erlotinib Importers in Myanmar
Showing top 10 of 6 known buyers in Myanmar receiving Erlotinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian erlotinib in Myanmar include WIN PHARMACY CO LTD, DIRECTORATE OF PROCUREMENTNAYPYTAW, DIRECTORATE OF PROCUREMENT , K T Z COMPANY LIMITED, THE MANAGER- BBJ CO LIMITED, among 6 total buyers. The largest importer is WIN PHARMACY CO LTD, accounting for $89.4K USD across 3 shipments — representing 75% of all erlotinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | WIN PHARMACY CO LTD | 3 | $89.4K | 75.1% |
| 2 | DIRECTORATE OF PROCUREMENTNAYPYTAW | 1 | $14.3K | 12.0% |
| 3 | DIRECTORATE OF PROCUREMENT | 1 | $8.4K | 7.0% |
| 4 | K T Z COMPANY LIMITED | 2 | $5.9K | 4.9% |
| 5 | THE MANAGER- BBJ CO LIMITED | 1 | $642 | 0.5% |
| 6 | DIRECTORATE OF PROCUREMENT | 1 | $477 | 0.4% |
Top 10 Erlotinib Formulations Imported by Myanmar
Showing top 10 of 6 product formulations shipped on the India to Myanmar Erlotinib route, ranked by trade value
Myanmar imports a wide range of erlotinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ERLOTEC 150 (ERLOTINIB TAB. 150MG)(P:1X10) (B.NO. ERTB5B3 MFG:02/25,E:01/27) — accounts for $89.4K USD across 3 shipments. A total of 6 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ERLOTEC 150 (ERLOTINIB TAB. 150MG)(P:1X10) (B.NO. ERTB5B3 MFG:02/25,E:01/27) | 3 | $89.4K | 75.1% |
| 2 | ERLOCEVA 100 ERLOTINIB 100 MG TAB | 1 | $14.3K | 12.0% |
| 3 | ERLOTINIB TABLETS 100MG (ERLOTED 100) | 1 | $8.4K | 7.0% |
| 4 | ERLOTAX 150 MG ERLOTINIB TABLET 150 MG PACKING 10 CAPS IN A BOTTLE | 2 | $5.9K | 4.9% |
| 5 | PHARMACEUTICALS PRODUCTSB.NO.ELP230407 M:4/23 E:3/25T:20 PKSP:1X30Erlotinib Tablets IP 150mg | 1 | $642 | 0.5% |
| 6 | ERLOTINIB TABLETS 100MG ERLOTED 100 40 PACKS X 3 X 10 TABLETS 1200TABLETS 120 PACKS | 1 | $477 | 0.4% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 3 shipments. Transit time averages 21 days by sea.
Market Dynamics
India's erlotinib exports to Myanmar are driven primarily by a handful of large-scale manufacturers. UNITED BIOTECH PRIVATE LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — UNITED BIOTECH PRIVATE LIMITED, BRUCK PHARMA PRIVATE LIMITED, THERDOSE PHARMA PRIVATE LIMITED — together account for 94% of total trade value on this route. The average shipment value of $13.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as erloceva 100 erlotinib 100 mg tab and erlotinib tablets 100mg (erloted 100) , suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, WIN PHARMACY CO LTD is the largest importer with 3 shipments worth $89.4K USD — representing 75% of all erlotinib imports from India on this route. A total of 6 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $119.0K
- Avg. Shipment
- $13.2K
- Suppliers
- 6
- Buyers
- 6
- Transit (Sea)
- ~21 days
- Annual Growth
- +17.3%
Other Erlotinib Routes
Unlock the Full India to Myanmar Erlotinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 9 shipments on this route.
Frequently Asked Questions — India to Myanmar Erlotinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Erlotinib to Myanmar?
The leading Indian exporters of Erlotinib to Myanmar are UNITED BIOTECH PRIVATE LIMITED, BRUCK PHARMA PRIVATE LIMITED, THERDOSE PHARMA PRIVATE LIMITED . UNITED BIOTECH PRIVATE LIMITED holds the largest market share at approximately 75% of total trade value on this route.
Q What is the total value of Erlotinib exports from India to Myanmar?
India exports Erlotinib to Myanmar worth approximately $119.0K USD across 9 recorded shipments. The average value per shipment is $13.2K USD.
Q Which ports does India use to ship Erlotinib to Myanmar?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 3 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Myanmar for Erlotinib?
The average transit time for Erlotinib shipments from India to Myanmar is approximately 21 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Myanmar Erlotinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 17.3% with demand growth tracking at 16.8%. The route is ranked #8 among India's top Erlotinib export destinations globally.
Q How many suppliers are active on the India to Myanmar Erlotinib route?
There are currently 6 active Indian suppliers exporting Erlotinib to Myanmar. The market is moderately concentrated with UNITED BIOTECH PRIVATE LIMITED accounting for 75% of total shipment value.
Q Who are the main importers of Erlotinib from India in Myanmar?
The leading importers of Indian Erlotinib in Myanmar include WIN PHARMACY CO LTD, DIRECTORATE OF PROCUREMENTNAYPYTAW, DIRECTORATE OF PROCUREMENT , K T Z COMPANY LIMITED, THE MANAGER- BBJ CO LIMITED. WIN PHARMACY CO LTD is the largest buyer with 3 shipments worth $89.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Myanmar export trade corridor identified from Indian Customs (DGFT) records for Erlotinib.
- 2.Supplier/Buyer Matching: 6 Indian exporters and 6 importers in Myanmar matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 9 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9 Verified Shipments
6 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists